Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD

Clinical trial NCT00191048 · COMPLETED

Trial details

NCT number: NCT00191048
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Attention-Deficit/Hyperactivity Disorder Comorbid Dyslexia

Start date: 2003-10-01
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.